Document is current
Any future updates will be listed below
-
Authors
Stegeman, Raymond
Nijman, Maaike
Breur, Johannes M. P. J.
Groenendaal, Floris
Haas, Felix
Derks, Jan B.
Nijman, Joppe
van Beynum, Ingrid M.
Taverne, Yannick J. H. J.
Bogers, Ad J. J. C.
Helbing, Willem A.
de Boode, Willem P.
Bos, Arend F.
Berger, Rolf M. F.
Accord, Ryan E.
Roes, Kit C. B.
de Wit, G. Ardine
Jansen, Nicolaas J. G.
Benders, Manon J. N. L. https://orcid.org/0000-0001-5491-9168
,
-
Funding
Funding for this research was provided by:
zonmw, goed geneesmiddelen gebruik, grote trials ronde 2 program (848042002)
hartekind foundation
friends of the wilhelmina children’s hospital foundation
- License Information
-
More Information
Article History
Received: 30 August 2021
Accepted: 10 February 2022
First Online: 23 February 2022
Declarations
:
: This trial is carried out in accordance with the Declaration of Helsinki and the guidelines of Good Clinical Practice. The trial was approved by the Medical Research Ethical Committee of the UMC Utrecht (reference number NL62772.041.18) and the Dutch competent authority “Centrale Commissie Mensgebonden Onderzoek” (reference number NL62772.041.18). Written informed consent will be collected from all parents or legal guardians before study participation.
: Not applicable.
: The authors declare that they have no competing interests.
